BioMarin Pharmaceutical Inc. (BVMF:B1MR34)
Brazil · Delayed Price · Currency is BRL 155.70
0.00 (0.00%)
At close: Feb 10, 2026
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 57.65 billion as of February 10, 2026. Its market cap has decreased by -17.35% in one year.
Market Cap
57.65B
Enterprise Value
53.12B
Revenue
16.49B
Ranking
n/a
PE Ratio
20.79
Stock Price
155.70
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 813.63M to 57.65B, an increase of 6,985.52%. That is a compound annual growth rate of 17.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 59.60B | -5.22% |
| Dec 31, 2025 | 62.89B | -18.83% |
| Dec 31, 2024 | 77.48B | -12.09% |
| Dec 29, 2023 | 88.13B | -13.33% |
| Dec 30, 2022 | 101.68B | 12.51% |
| Dec 31, 2021 | 90.38B | 9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 93.04B |
| Raia Drogasil | 46.55B |
| Hypera | 15.01B |
| Fleury | 9.23B |
| Odontoprev | 6.46B |
| Diagnósticos da América | 5.27B |
| Empreendimentos Pague Menos | 4.37B |
| Oncoclínicas do Brasil Serviços Médicos | 2.85B |